- Real Time Charts
- Forex Charts
- Futures Charts
- Stocks Charts
- Indices Charts
Feb 13, 2012 12:39AM GMT
New York London Tokyo
US FDA staff--Targanta drug seems similar to rival
By Reuters | General News | Nov 17, 2008 01:57PM GMT
Reuters
NEW YORK, Nov 17 (Reuters) - Targanta Therapeutics Corp's clinical trial data shows its antibiotic is about as safe and effective as another similar drug already on the U.S. market, Food and Drug Administration staff said on Monday.
In general, the results for Targanta's oritavancin are comparable to those for vancomycin, another antibiotic sold by several other companies, FDA staff said in documents released ahead of an advisory committee meeting on Wednesday.
The FDA is seeking its adviser's recommendation on whether to approve the drug to treat complicated skin infections. (Reporting by Susan Heavey)
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data .
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
CFDs Quotes
| SPX 500 Futures | 1345.45 | +4.95 | +0.37% | |||
| NQ 100 Futures | 2557.20 | +8.70 | +0.34% | |||
| US 30 | 12801.23 | -89.23 | -0.69% | |||
| DAX | 6692.96 | -95.84 | -1.41% | |||
| UK 100 | 5852.39 | -43.08 | -0.73% | |||
| Japan 225 | 8975.50 | +28.33 | +0.32% | |||
| US Dollar Index | 79.07 | -0.04 | -0.05% |
CFDs Quotes
| Gold | 1723.95 | -1.35 | -0.08% | |||
| Silver | 33.645 | +0.041 | +0.12% | |||
| Copper | 3.877 | +0.015 | +0.39% | |||
| Crude Oil | 99.53 | +0.50 | +0.50% | |||
| Natural Gas | 2.428 | -0.048 | -1.94% | |||
| US Cotton No.2 | 91.03 | +0.65 | +0.72% | |||
| US Coffee C | 218.60 | +0.00 | +0.00% |
CFDs Quotes
| Euro Bund | 138.66 | +1.41 | +1.03% | |||
| Italian Govt. B. | 102.45 | -1.63 | -1.57% | |||
| Euro BOBL | 125.23 | +0.71 | +0.57% | |||
| UK Gilt | 115.78 | +1.13 | +0.99% | |||
| US 2 YR T-Note | 110.26 | -0.02 | -0.02% | |||
| US 10 YR T-Note | 131.18 | -0.03 | -0.02% | |||
| US 30 YR T-Bond | 142.39 | -0.04 | -0.03% |
Recent Activity
Sponsored Links
- 50% Bonus with 4XP and ForexProsEnjoy the best offer in the forex market
a massive 50% bonus from 4XP and ForexPros - Even beginners can trade like expertsFree Trading Course & Demo Account. Multiple Trading Systems Available.
- Be a 4XP Pro - AutomaticallyUse 4XP Auto-Trading to automatically maximize your profits